Expert Point of View: Anita Mahajan, MD

This study pushes the envelope of how to use our therapies to give the most benefit to patients we otherwise wouldn't be treating: in this case, children under the age of 3. This age group has historically been a 'no man's land.' Now we see we can treat children as young as 1 year," said Anita

from #MedicinebyAlexandrosSfakianakis via xlomafota13 on Inoreader http://ift.tt/1TgsS0D
via IFTTT